![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Hologic’s Bordetella Assay Earns CE Mark
Hologic’s Bordetella Assay Earns CE Mark
![Hologic logo](https://www.fdanews.com/ext/resources/test/Device_Images6/Hologic_Logo.gif?t=1624653890&width=430)
October 12, 2018
Hologic received the CE Mark for its Panther Fusion Bordetella assay, expanding the menu of the molecular testing device.
The real-time PCR assay can detect and differentiate between B. pertussis and B. parapertussis from samples collected from the patient’s nasopharynx.
Because the assay can differentiate between the two bacteria, which are known to cause whooping cough, it enables physicians to prescribe the right antibiotic for the patient.
Upcoming Events
-
21Oct